开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2024-03-16 ms2000000377501383 来自北京

偏重的研究方向：基因组学
经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗

74 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2023-07-25 1ddf3775m09(暂无匿称) 来自江苏省

这杂志的Editorial Assessment一般要多久？

131 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2024-03-30 ms7000001623486299 来自江苏省

请问，这个期刊收letter么

65 0

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2023-02-07 2333 来自上海

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：质粒接合转移
经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了

125 0

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2022-04-08 ms9000000951982537

genome medicine多久会拒稿呀

140 0

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

引言需要写什么内容？

144 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

引言一般分几段？

150 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2021-02-22 ms5000000102404504

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肠道宏基因组
经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。

206 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2020-07-15 princesun083

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤免疫微环境;RNA Biology
经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了...

320 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193571, encodeId=486121935e1ee, content=偏重的研究方向：基因组学 经验分享：外审3个多月了，现在是编辑评估状态10天了，被拒稿的可能性大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb378337322, createdName=ms2000000377501383, createdTime=Sat Mar 16 14:20:50 CST 2024, time=2024-03-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149789, encodeId=03ac2149e89b4, content=这杂志的Editorial Assessment一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Tue Jul 25 19:14:51 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196232, encodeId=dc1c21962327e, content=请问，这个期刊收letter么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sat Mar 30 16:39:20 CST 2024, time=2024-03-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2113373, encodeId=c45721133e3c4, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：质粒接合转移 经验分享：初审一个月，回答问题为主，没有补实验，二审两个多月，邮件催了两次，截至接受共4个月。第二篇一星期给拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08675519226, createdName=2333, createdTime=Tue Feb 07 10:19:07 CST 2023, time=2023-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1209586, encodeId=d1f512095865c, content=genome medicine多久会拒稿呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea96587927, createdName=ms9000000951982537, createdTime=Fri Apr 08 15:36:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105280, encodeId=d4381105280c1, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105279, encodeId=80a811052e92b, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926395, encodeId=5ccf926395f1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肠道宏基因组 经验分享：19年12月底投稿，20年6月才返回审稿意见，中间换过一回编辑，催了3-4次，最后审稿意见回来编辑直接拒了。审稿很慢很难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c15462049, createdName=ms5000000102404504, createdTime=Mon Feb 22 16:08:52 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802853, encodeId=ad86802853f9, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫微环境;RNA Biology 经验分享：一审3个半月，给了大修，补实验超了一个月时间，申请延迟修回，二审3个月，给了小修，补了点细胞实验，一个月后修回，三审1个半月，所有审稿人没有问题。这时候编辑说文章方法部分的文字描述跟我之前的文章有较大部分的重复，需要降重。然后花了三周时间仔细修改语言，查了两次重，随后修回，四审1个月（不知道为什么这么慢），接收！2周后校稿，再三周后在线发表。总体而言，发表难度挺大，数据量也超级多，累脱了皮。槽点：杂志社处理稿件速度太慢了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Wed Jul 15 11:15:25 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901626, encodeId=908290162681, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6c82322330, createdName=hlksrv, createdTime=Tue Nov 24 01:44:07 CST 2020, time=2020-11-24, status=1, ipAttribution=)]

2020-11-24 hlksrv

审稿速度:12.0 | 投稿命中率:25.0
经验分享：疫情期间：初审四个月，四个审稿人，意见以回答问题为主，两周修回；二审三个月，原则接收；按编辑要求改格式一个月，正式接收；校稿缴费一个月，online。时间充裕的可投，着急的不建议；国人命中率低，客气但拖沓，拖到没脾气，不太友好。

14 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务